These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38855784)

  • 1. Efficacy and Safety of Upadacitinib Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis as Induction for Intractable Ulcerative Colitis.
    Tanida S; Sasoh S; Otani T; Kubota Y; Ban T; Ando T; Nakamura M; Joh T
    J Clin Med Res; 2024 May; 16(5):256-263. PubMed ID: 38855784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination Therapy With Tofacitinib Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis as Induction Therapy for Refractory Ulcerative Colitis.
    Tanida S; Ozeki K; Mizoshita T; Kitagawa M; Ozeki T; Tanaka M; Nishie H; Shimura T; Kubota E; Kataoka H
    J Clin Med Res; 2020 Jan; 12(1):36-40. PubMed ID: 32010420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction Therapy With a Combination of Weekly Adalimumab Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis in Patients With Ulcerative Colitis and Failure of Conventional Agents, Biologics and Janus Kinase Inhibitor.
    Tanida S; Ozeki K; Katano T; Tanaka M; Shimura T; Kubota E; Kataoka H; Takahama T; Sasoh S; Kubota Y; Ban T; Ando T; Nakamura M; Joh T
    J Clin Med Res; 2023 Mar; 15(3):181-186. PubMed ID: 37035853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination Therapy With Adalimumab Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis in Patients With Refractory Ulcerative Colitis.
    Tanida S; Mizoshita T; Nishie H; Ozeki K; Katano T; Kubota E; Kataoka H; Kamiya T; Joh T
    J Clin Med Res; 2015 Nov; 7(11):884-9. PubMed ID: 26491502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upadacitinib Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis for Ulcerative Colitis Achieved Ulcer Healing for Pyoderma Gangrenosum.
    Tanida S; Kubo R; Yoshii S; Takahama T; Sasoh S; Kubota Y; Ban T; Ando T; Nakamura M; Joh T
    J Clin Med Res; 2023 Dec; 15(10-11):446-455. PubMed ID: 38189038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination Therapy With Ustekinumab Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis in Patients With Refractory Ulcerative Colitis.
    Tanida S; Ozeki K; Kanno T; Katano T; Sugimura N; Nishie H; Iwasaki H; Tanaka M; Shimura T; Kubota E; Kataoka H
    J Clin Med Res; 2021 Nov; 13(10-11):510-514. PubMed ID: 34925662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensive Frequent Granulocyte Adsorptive Apheresis Therapy for Acute Fulminant Ulcerative Colitis: Two Consecutive Case Reports.
    Furuto Y; Sawada R; Namikawa A; Matsuhashi N; Shibuya Y
    Cureus; 2023 Aug; 15(8):e43599. PubMed ID: 37719478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal calprotectin is a useful biomarker for predicting the clinical outcome of granulocyte and monocyte adsorptive apheresis in ulcerative colitis patients: a prospective observation study.
    Ueno N; Sugiyama Y; Kobayashi Y; Murakami Y; Iwama T; Sasaki T; Kunogi T; Takahashi K; Tanaka K; Ando K; Kashima S; Inaba Y; Moriichi K; Tanabe H; Taruishi M; Saitoh Y; Okumura T; Fujiya M
    BMC Gastroenterol; 2021 Aug; 21(1):316. PubMed ID: 34362299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An open-label prospective randomized multicenter study shows very rapid remission of ulcerative colitis by intensive granulocyte and monocyte adsorptive apheresis as compared with routine weekly treatment.
    Sakuraba A; Motoya S; Watanabe K; Nishishita M; Kanke K; Matsui T; Suzuki Y; Oshima T; Kunisaki R; Matsumoto T; Hanai H; Fukunaga K; Yoshimura N; Chiba T; Funakoshi S; Aoyama N; Andoh A; Nakase H; Mizuta Y; Suzuki R; Akamatsu T; Iizuka M; Ashida T; Hibi T
    Am J Gastroenterol; 2009 Dec; 104(12):2990-5. PubMed ID: 19724269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of children and adolescents with ulcerative colitis by adsorptive depletion of myeloid lineage leucocytes as monotherapy or in combination with low dose prednisolone after failure of first-line medications.
    Tanaka T; Sugiyama S; Goishi H; Kajihara T; Akagi M; Miura T
    BMC Gastroenterol; 2013 Aug; 13():130. PubMed ID: 23961883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Usefulness of New Single-Needle Intensive Granulocyte and Monocyte Adsorptive Apheresis in Active Ulcerative Colitis Patients Without Corticosteroids and Biologics.
    Shimazu K; Fukuchi T; Kim I; Noguchi Y; Iwata M; Koyama S; Ubukata S; Tanaka A
    Ther Apher Dial; 2016 Aug; 20(4):383-9. PubMed ID: 27523079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of upadacitinib maintenance therapy for moderately to severely active ulcerative colitis in patients responding to 8 week induction therapy (U-ACHIEVE Maintenance): overall results from the randomised, placebo-controlled, double-blind, phase 3 maintenance study.
    Vermeire S; Danese S; Zhou W; Ilo D; Klaff J; Levy G; Yao X; Chen S; Sanchez Gonzalez Y; Hébuterne X; Lindsay JO; Higgins PDR; Cao Q; Nakase H; Colombel JF; Loftus EV; Panaccione R
    Lancet Gastroenterol Hepatol; 2023 Nov; 8(11):976-989. PubMed ID: 37683686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination Therapy with Intensive Granulocyte and Monocyte Adsorptive Apheresis plus Adalimumab: Therapeutic Outcomes in 5 Cases with Refractory Crohn's Disease.
    Ozeki K; Tanida S; Mizoshita T; Tsukamoto H; Ebi M; Mori Y; Kataoka H; Kamiya T; Joh T
    Case Rep Gastroenterol; 2012 Sep; 6(3):765-71. PubMed ID: 23341799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant pharmacologic medications influence the clinical outcomes of granulocyte and monocyte adsorptive apheresis in patients with ulcerative colitis: A multicenter retrospective cohort study.
    Ueno N; Sugiyama Y; Kobayashi Y; Murakami Y; Iwama T; Sasaki T; Kunogi T; Sakatani A; Takahashi K; Tanaka K; Serikawa S; Ando K; Kashima S; Muto M; Inaba Y; Moriichi K; Tanabe H; Okumura T; Fujiya M
    J Clin Apher; 2023 Aug; 38(4):406-421. PubMed ID: 36636880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of mucosal healing by intensive granulocyte/monocyte adsorptive apheresis (GMA) without use of corticosteroids in patients with ulcerative colitis: long-term remission maintenance after induction by GMA and efficacy of GMA re-treatment upon relapse.
    Fukuchi T; Kawashima K; Koga H; Utsunomiya R; Sugiyama K; Shimazu K; Eguchi T; Ishihara S
    J Clin Biochem Nutr; 2022 Mar; 70(2):197-204. PubMed ID: 35400813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adsorptive Granulocyte and Monocyte Apheresis Is Effective in Ulcerative Colitis Patients Both with and without Concomitant Prednisolone.
    Matsuda K; Ohno K; Okada Y; Yagi T; Tsukamoto M; Fukushima Y; Horiuchi A; Shimada R; Ozawa T; Hayama T; Tsuchiya T; Tamura J; Iinuma H; Nozawa K; Aoyagi H; Isono A; Abe K; Kodashima S; Yamamoto T; Kawasaki Y; Tamura Y; Sasajima Y; Kondo F; Hashiguchi Y
    Inflamm Intest Dis; 2020 Feb; 5(1):36-41. PubMed ID: 32232053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of granulocyte and monocyte apheresis for antibiotic-refractory pouchitis after proctocolectomy for ulcerative colitis: an open-label, prospective, multicentre study.
    Yamamoto T; Tanaka T; Yokoyama T; Shimoyama T; Ikeuchi H; Uchino M; Watanabe T
    Therap Adv Gastroenterol; 2017 Feb; 10(2):199-206. PubMed ID: 28203278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-Needle Intensive Granulocyte and Monocyte Adsorptive Apheresis Is Suitable for Elderly Patients With Active Ulcerative Colitis Taking no Corticosteroids or Biologics.
    Fukuchi T; Koga H; Kaichi S; Ishikawa A; Horita T; Araki R; Yokota A; Namba Y; Kyo M; Eguchi T; Shimazu K
    Ther Apher Dial; 2019 Jun; 23(3):224-232. PubMed ID: 31025824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adsorptive Granulocyte and Monocyte Apheresis in the Treatment of Ulcerative Colitis: The First Multicenter Study in China.
    Lai YM; Yao WY; He Y; Jiang X; Gu YB; Chen MH; Liu YL; Yuan YZ; Qian JM
    Gut Liver; 2017 Mar; 11(2):216-225. PubMed ID: 27843131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials.
    Danese S; Vermeire S; Zhou W; Pangan AL; Siffledeen J; Greenbloom S; Hébuterne X; D'Haens G; Nakase H; Panés J; Higgins PDR; Juillerat P; Lindsay JO; Loftus EV; Sandborn WJ; Reinisch W; Chen MH; Sanchez Gonzalez Y; Huang B; Xie W; Liu J; Weinreich MA; Panaccione R
    Lancet; 2022 Jun; 399(10341):2113-2128. PubMed ID: 35644166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.